Oral Minoxidil for Male Hair Loss Treatment
Treatments studied
Part of Skin clinical trials.
This trial tests a new oral (pill) form of minoxidil to help regrow hair in men with male-pattern baldness. Minoxidil is a known hair-growth medication, and this study evaluates whether taking it as a pill works safely and effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 to 60 years old
- You have male-pattern baldness (androgenetic alopecia) at moderate to advanced stages
- You have not used hair-loss treatments in the last 6 months (or only briefly within that timeframe)
- You are willing to shave a small target area on your scalp and get a permanent tiny tattoo mark for measurement purposes
- You agree to keep your hairstyle, hair length, and hair color the same throughout the study
- You do not have other scalp conditions, heart problems, kidney disease, or uncontrolled high blood pressure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a low-dose oral form of minoxidil (a common hair-loss medicine) can help people with mild to severe male or female pattern baldness.
This Phase 3 trial tests whether a 1 mg oral minoxidil pill helps improve hair thinning in women and checks its safety. If you match the study’s hair-loss pattern and can follow the visit and medication routine, you may be able to join.
This study tests whether microneedling, a procedure that uses tiny needles to stimulate the scalp, can help treat male pattern baldness. It may help regrow hair in men with moderate to advanced hair loss.
This trial tests a 5% minoxidil foam to treat female pattern hair loss. It may help women who have been diagnosed with this condition and have mild to moderate hair thinning.
This Phase 3 study tests whether a specific hair lotion works and is safe for men with male pattern hair loss. It also checks that results are consistent while you keep similar hair care and avoid certain other hair-loss treatments.
This study compares a new peptide-based hair serum with minoxidil (a common hair-regrowth treatment) in people with androgenetic alopecia, a type of hair loss caused by genetics and hormones. The trial lasts 24 weeks and measures how well each treatment works.
Hear when a new Androgenetic Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.